The Use of Vaccines in Adult Patients With Renal Disease Mara Dinits-Pensy, MD, Graeme N. Forrest, MD, Alan S. Cross, MD, Michael K. Hise, MD American Journal of Kidney Diseases Volume 46, Issue 6, Pages 997-1011 (December 2005) DOI: 10.1053/j.ajkd.2005.08.032 Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions
Fig 1 Adjusted mortality rates in dialysis patients after the first pneumonia event. Data obtained from 194,374 incident dialysis patients, 1996 to 2000. Rates adjusted for age, sex, race, primary diagnosis, and vintage. Patients without pneumonia were used as the reference cohort. Data from USRDS 2004 Annual Data Report. 1 American Journal of Kidney Diseases 2005 46, 997-1011DOI: (10.1053/j.ajkd.2005.08.032) Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions
Fig 2 Adjusted cardiovascular event rates in dialysis patients after the first pneumonia event. Data obtained from 78,262 incident dialysis patients, 1996 to 2000. Rates adjusted for age, sex, race, primary diagnosis, and vintage. Patients without pneumonia were used as the reference cohort. Data from USRDS 2004 Annual Data Report. 1 American Journal of Kidney Diseases 2005 46, 997-1011DOI: (10.1053/j.ajkd.2005.08.032) Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions
Fig 3 Hospital admission rates for septicemia during the first year on peritoneal dialysis (PD) or hemodialysis (HD), 1991 to 2001. Septicemia rates in patients on hemodialysis therapy continue to increase, whereas rates in peritoneal dialysis patients have remained stable and are consistently lower. Rates adjusted for age, sex, race, and primary diagnosis. Data from USRDS 2004 Annual Data Report.1 American Journal of Kidney Diseases 2005 46, 997-1011DOI: (10.1053/j.ajkd.2005.08.032) Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions